PMGC (ELAB) Competitors $2.26 -0.05 (-2.16%) Closing price 07/3/2025 03:26 PM EasternExtended Trading$2.26 0.00 (0.00%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELAB vs. PHIO, BCDA, PHXM, AIMD, CSCI, TRIB, GLYC, NKGN, KPRX, and BTAIShould you be buying PMGC stock or one of its competitors? The main competitors of PMGC include Phio Pharmaceuticals (PHIO), BioCardia (BCDA), PHAXIAM Therapeutics (PHXM), Ainos (AIMD), COSCIENS Biopharma (CSCI), Trinity Biotech (TRIB), GlycoMimetics (GLYC), NKGen Biotech (NKGN), Kiora Pharmaceuticals (KPRX), and BioXcel Therapeutics (BTAI). These companies are all part of the "pharmaceutical products" industry. PMGC vs. Its Competitors Phio Pharmaceuticals BioCardia PHAXIAM Therapeutics Ainos COSCIENS Biopharma Trinity Biotech GlycoMimetics NKGen Biotech Kiora Pharmaceuticals BioXcel Therapeutics Phio Pharmaceuticals (NASDAQ:PHIO) and PMGC (NASDAQ:ELAB) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership. Is PHIO or ELAB more profitable? PMGC's return on equity of -77.80% beat Phio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Phio PharmaceuticalsN/A -105.65% -89.19% PMGC N/A -77.80%-59.17% Does the media refer more to PHIO or ELAB? In the previous week, Phio Pharmaceuticals and Phio Pharmaceuticals both had 1 articles in the media. Phio Pharmaceuticals' average media sentiment score of 0.50 beat PMGC's score of 0.00 indicating that Phio Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phio Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PMGC 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer PHIO or ELAB? Phio Pharmaceuticals presently has a consensus target price of $14.00, suggesting a potential upside of 475.18%. Given Phio Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts clearly believe Phio Pharmaceuticals is more favorable than PMGC.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phio Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00PMGC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings and valuation, PHIO or ELAB? Phio Pharmaceuticals is trading at a lower price-to-earnings ratio than PMGC, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhio PharmaceuticalsN/AN/A-$7.15M-$10.92-0.22PMGCN/AN/A-$6.25M-$433.87-0.01 Which has more risk and volatility, PHIO or ELAB? Phio Pharmaceuticals has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, PMGC has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500. Do institutionals and insiders have more ownership in PHIO or ELAB? 57.3% of Phio Pharmaceuticals shares are held by institutional investors. Comparatively, 22.2% of PMGC shares are held by institutional investors. 0.6% of Phio Pharmaceuticals shares are held by insiders. Comparatively, 0.6% of PMGC shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryPhio Pharmaceuticals beats PMGC on 7 of the 12 factors compared between the two stocks. Get PMGC News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAB vs. The Competition Export to ExcelMetricPMGCDIVERSIFIED OPS IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$3.11M$16.01B$14.70B$9.02BDividend YieldN/A4.39%4.13%4.10%P/E Ratio-0.018.637.3520.28Price / SalesN/A4.323.60121.46Price / CashN/A33.0931.7957.47Price / Book0.202.362.085.68Net Income-$6.25M$951.45M$922.22M$248.96M7 Day Performance5.61%3.26%2.90%3.30%1 Month Performance2.26%0.67%-0.14%5.20%1 Year Performance-99.72%-6.43%-4.92%21.37% PMGC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELABPMGC0.0795 of 5 stars$2.26-2.2%N/A-99.7%$3.11MN/A-0.0118Gap UpPHIOPhio Pharmaceuticals2.7938 of 5 stars$2.18-4.0%$14.00+542.2%-53.4%$10.87MN/A-0.2010BCDABioCardia4.0078 of 5 stars$2.02-2.9%$25.00+1,137.6%-29.4%$10.77M$3K-0.8740News CoveragePositive NewsInsider TradeGap DownPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049AIMDAinos0.854 of 5 stars$0.50-1.7%N/A-30.0%$10.49M$20K-0.3940CSCICOSCIENS BiopharmaN/A$3.36+1.8%N/AN/A$10.38M$9.59M-0.5820TRIBTrinity Biotech0.4077 of 5 stars$0.55-2.6%N/A-65.6%$10.25M$61.56M-0.20480Gap UpGLYCGlycoMimetics1.2243 of 5 stars$0.16-6.6%N/A-99.4%$10.00M$10K-0.3450High Trading VolumeNKGNNKGen BiotechN/A$0.22-11.0%N/A-77.3%$10.00M$80K-0.04N/AKPRXKiora Pharmaceuticals2.3393 of 5 stars$3.13-2.2%$10.00+219.5%-33.9%$9.74M$16.02M-1.0810BTAIBioXcel Therapeutics4.3279 of 5 stars$1.65+3.1%$42.60+2,481.8%-88.7%$9.69M$2.27M-0.1290Gap Up Related Companies and Tools Related Companies PHIO Alternatives BCDA Alternatives PHXM Alternatives AIMD Alternatives CSCI Alternatives TRIB Alternatives GLYC Alternatives NKGN Alternatives KPRX Alternatives BTAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ELAB) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMGC Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMGC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELAB Stock Alerts